Series A funding round for Mirador Therapeutics raising $400M in March 2024
Series A funding round for Mirador Therapeutics raising $400M in March 2024
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Hedge Fund | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Hedge Fund | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$650M
Top Valuation
-
Mirador Therapeutics raised $400M in a Series A round.
The round was announced on 03/01/24.
The round was led by ARCH Venture Partners.